body.layout-boxed.body--hand-drawn .handborder--left,body.layout-boxed.body--hand-drawn .handborder--right{--wpr-bg-6277b9c0-a2b2-473f-8682-ab8c1fce90e9: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/line.webp');}body.layout-boxed.body--hand-drawn .handborder--top,body.layout-boxed.body--hand-drawn .handborder--bottom{--wpr-bg-19248338-2ba6-43bf-bfb4-48a78ea29f5f: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/line-h.webp');}blockquote:before,.wp-block-quote.is-large:before,.wp-block-quote.is-style-large:before{--wpr-bg-3b2638fa-e491-48f3-bdb2-e3f6f0a5c868: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote.webp');}.style--blockquote--icon-2 blockquote:before,.style--blockquote--icon-2 .wp-block-quote.is-large:before,.style--blockquote--icon-2 .wp-block-quote.is-style-large:before{--wpr-bg-46e9a6a7-e160-4edf-9328-ca1b8ceb31bf: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote2.webp');}.style--blockquote--icon-3 blockquote:before,.style--blockquote--icon-3 .wp-block-quote.is-large:before,.style--blockquote--icon-3 .wp-block-quote.is-style-large:before{--wpr-bg-bc7ee997-2b33-4b01-9b5b-9ffec9091cf2: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote3.webp');}.style--blockquote--icon-4 blockquote:before,.style--blockquote--icon-4 .wp-block-quote.is-large:before,.style--blockquote--icon-4 .wp-block-quote.is-style-large:before{--wpr-bg-35add0a5-710b-4b20-8646-50fecbfd243c: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote4.webp');}.no-webp blockquote:before,.no-webp .wp-block-quote.is-large:before,.no-webp .wp-block-quote.is-style-large:before{--wpr-bg-edbd278e-2eb4-49da-bc89-75f945705a9b: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote.png');}.no-webp .style--blockquote--icon-2 blockquote:before,.no-webp .style--blockquote--icon-2 .wp-block-quote.is-large:before,.no-webp .style--blockquote--icon-2 .wp-block-quote.is-style-large:before{--wpr-bg-25431d9c-0a3d-4ea9-a19f-c5e5dd1583f8: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote2.png');}.no-webp .style--blockquote--icon-3 blockquote:before,.no-webp .style--blockquote--icon-3 .wp-block-quote.is-large:before,.no-webp .style--blockquote--icon-3 .wp-block-quote.is-style-large:before{--wpr-bg-dd65ad0f-d85b-4e62-9011-48b1546b00bf: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote3.png');}.no-webp .style--blockquote--icon-4 blockquote:before,.no-webp .style--blockquote--icon-4 .wp-block-quote.is-large:before,.no-webp .style--blockquote--icon-4 .wp-block-quote.is-style-large:before{--wpr-bg-9b487a24-1faa-4329-82e6-ab2e78a353c3: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote4.png');}.fox-library-modal-btn:before{--wpr-bg-4ac3b2b7-5d8e-43d9-89fe-34a30412bb81: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/foxhead.png');}.rll-youtube-player .play{--wpr-bg-344e9a49-39b0-46ca-963d-a4fbe3e0cff4: url('https://b6620556.delivery.rocketcdn.me/wp-content/plugins/wp-rocket/assets/img/youtube.png');}

mabxience

Ciencia y Tecnología·Coronavirus y Salud·Información

Empresa española es elegida por OMS para desarrollar anticuerpo contra virus

Mar 9, 2016

Por Paula Grieco

La empresa española mAbxience, especializada en producir medicamentos biosimilares, liderará el desarrollo de un anticuerpo utilizado para prevenir el Virus Respiratorio Sincitial (VRS), segunda

Ir aArriba